References: Monitoring of dabigatran

  • Favaloro EJ, Pasalic L, Curnow J, Lippi G. Laboratory Monitoring or Measurement of Direct Oral Anticoagulants (DOACs): Advantages, Limitations and Future Challenges. Curr Drug Metab 2017;18(7):598-608. https://www.ncbi.nlm.nih.gov/pubmed/28413976